Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Bruker is lead sponsor; 0 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-08-14Current report (material event)
- SCHEDULE 13G/A2026-08-06SCHEDULE 13G/A
- 10-Q2026-08-05Quarterly report
- 8-K2026-08-04Current report (material event)
- 8-K2026-07-30Current report (material event)
- S-3ASR2026-06-12S-3ASR
- SD2026-05-29SD
- 8-K/A2026-05-29Current report (amended)
- 8-K2026-05-21Current report (material event)
- 8-K2026-05-15Current report (material event)
- SCHEDULE 13G/A2026-05-15SCHEDULE 13G/A
- 10-Q2026-05-07Quarterly report
- SCHEDULE 13G/A2026-05-06SCHEDULE 13G/A
- 8-K2026-05-06Current report (material event)
- 8-K2026-04-28Current report (material event)
- ARS2026-04-10Annual report to holders
- DEFA14A2026-04-10DEFA14A
- DEF 14A2026-04-10Proxy statement
- 8-K2026-04-10Current report (material event)
- 8-K2026-04-01Current report (material event)
- SCHEDULE 13G/A2026-03-26SCHEDULE 13G/A
- SCHEDULE 13G/A2026-03-06SCHEDULE 13G/A
- S-8 POS2026-02-27S-8 POS
- S-82026-02-27Employee stock plan
- 10-K2026-02-27Annual report
- 8-K2026-02-20Current report (material event)
- SCHEDULE 13G/A2026-02-17SCHEDULE 13G/A
- SCHEDULE 13G/A2026-02-17SCHEDULE 13G/A
- 8-K2026-02-12Current report (material event)
- 8-K2026-01-12Current report (material event)
- 8-K2025-12-09Current report (material event)
- SCHEDULE 13G2025-11-14SCHEDULE 13G
- SCHEDULE 13G/A2025-11-14SCHEDULE 13G/A
- 10-Q2025-11-05Quarterly report
- 8-K2025-11-03Current report (material event)
- SCHEDULE 13G/A2025-10-07SCHEDULE 13G/A
- CERT2025-09-08CERT
- 8-A12B2025-09-088-A12B
- 8-K2025-09-08Current report (material event)
- 424B52025-09-05Prospectus (offering)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.